The prestigious award recognises Professor Chris Goodnow's innovative work on immune tolerance and chronic disease.Professor ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

By Christy Santhosh (Reuters) -AbbVie said on Monday it would acquire privately held cell therapy developer Capstan ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class ...

在医学科研的前沿阵地，澳大利亚科研团队在 Cellular&Molecular Immunology 期刊上发表了一篇题为 “Adjusting the scope of natural killer cells in cancer therapy” ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...

Advanced imaging technologies are uncovering surprising roles for CD8+ T cells—not just in immune defense, but also in supporting tissue repair and regeneration.

Cancer: «forgotten» cells go on the offensive. UNIGE Immunologists have discovered the yet unsuspected anti-tumour potential ...

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...

Northwestern Medicine investigators have identified a surprising culprit in the progression of inflammatory bowel disease: a ...

Systemic sclerosis (SSc) or scleroderma is a rare, chronic, autoimmune disorder that hardens connective tissue and muscle in ...